Europe narcolepsy market is anticipated to reach US$ 1,532.5 Mn in 2027 from US$ 671.1Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.7% from 2019-2027.
The narcolepsy market is estimated to grow due to the key driving factors such as growing research and developments and increasing awareness across the region. However, the factor such as challenges related to narcolepsy is likely to act as major restraining factor for the growth of the market.
Narcolepsy is a rare chronic sleep disorder that is caused due to the loss of neurons that produces hypocretin. Various developments have been made to make medicines that can reduce the symptoms of narcolepsy. Several research and developments are being conducted across countries such as Germany, the UK, and other countries in the European region. For instance, in April 2019, in Germany, research and development activities were carried out at Inserm and Université de Montpellier. The research was conducted in collaboration with international teams that helped to conducted studies for epidemiological and clinical research for the drug Solriamfetol among the people living with narcolepsy.
In addition, the study was conducted in collaboration with Jazz Pharmaceuticals, the company has invested in the trial, and it also holds a license to develop and commercialize Solriamfetol. The study was a phase III clinical trial, and the results showed that the drug has no side effects to the patients living with narcolepsy. Thus, owing to growing research and development activities for narcolepsy is likely to enhance the growth of the market during the forecast period.
Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Narcolepsy – Market Segmentation
Europe Narcolepsy Market – By Type
- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Narcolepsy
Europe Market – By Product
- Central Nervous System (CNS) Stimulants
- Sodium Oxybate
- Antidepressants
Europe Market – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
By Geography
Europe
- US
- Canada
- Mexico
Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals plc
- Arena Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- BIOPROJET
- Shionogi & Co., Ltd.
- Ligand Pharmaceuticals, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Product Stimulants, Distribution Channel and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. Europe Narcolepsy Market – Key Takeaways
3. Europe Narcolepsy Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Narcolepsy Market – By Type
3.2.2 Europe Narcolepsy Market – By Product
3.2.3 Europe Narcolepsy Market – By Distribution Channel
3.2.4 Europe Narcolepsy Market – By Country
3.3 PEST Analysis
4. Europe Narcolepsy Market-Key Dynamics
4.1 Key Market Drivers
4.1.1 Growing Research and Developments
4.1.2 Increasing Awareness Across the Region
4.2 Key Market Restraints
4.2.1 Challenge Related to Narcolepsy
4.3 Key Market Opportunity
4.3.1 Reimbursement For Drugs
4.4 Future Trend
4.4.1 Developments in Pharmaceutical Sector to Treat Narcolepsy
4.5 Impact Analysis Of Drivers and Restraints
5. Narcolepsy Market – Regional Analysis
5.1 Europe Narcolepsy Market Revenue Forecasts and Analysis
5.2 Performance Of Key Players
5.2.1 Jazz Pharmaceuticals plc
5.2.2 Teva Pharmaceutical Industries Ltd.
6. Narcolepsy Market Analysis and Forecasts to 2027 – Type
6.1 Overview
6.2 Type Market Revenue and Forecasts Analysis (US$ Mn)
6.3 Europe Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (Us$ Mn)
6.4 Narcolepsy With Cataplexy Market
6.4.1 Overview
6.4.2 Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Narcolepsy Without Cataplexy Market
6.5.1 Overview
6.5.2 Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Secondary Narcolepsy Market
6.6.1 Overview
6.6.2 Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)
7. Narcolepsy Market Analysis and Forecasts to 2027 – Product
7.1 Overview
7.2 Product Market Revenue and Forecasts Analysis (US$ Mn)
7.3 Europe Narcolespy Market Revenue and Forecasts To 2027, By Product (US$ Mn)
7.4 Central Nervous System Stimulants Market
7.4.1 Overview
7.4.2 Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Sodium Oxybate Market
7.5.1 Overview
7.5.2 Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Antidepressants Market
7.6.1 Overview
7.6.2 Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)
8. Narcolepsy Market Analysis and Forecasts to 2027 – Distribution Channel
8.1 Overview
8.2 Distribution Channel Market Revenue and Forecasts Analysis (US$ Mn)
8.3 Europe Narcolespy Market Revenue and Forecasts To 2027, By End User (US$ Mn)
8.4 Hospital Pharmacies Market
8.4.1 Overview
8.4.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Retail Pharmacies Market
8.5.1 Overview
8.5.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9. Narcolepsy Market Revenue And Forecasts To 2027 – Geographical Analysis
9.1 Europe Narcolepsy Market
9.1.1 Overview
9.1.2 Europe Narcolepsy Market Revenue Overview, by Country (2017) (US$ Mn)
9.1.3 Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.4 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.5 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.7 Europe Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)
9.1.8 Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9 Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.9.3 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.10 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.1 UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.11.2 UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.11.3 UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.12 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.13 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.13.1 France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.13.2 France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.13.3 France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.14 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.15 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.15.1 Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.15.2 Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.15.3 Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
9.1.16 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.17 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.17.1 Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.17.2 Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.17.3 Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10. Narcolepsy Market – Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By The Companies In The Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Narcolepsy Market –Key Company Profiles
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Jazz Pharmaceuticals Plc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Arena Pharmaceuticals, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Graymark Healthcare, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Takeda Pharmaceutical Company Limited
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Pipeline
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Mylan N.V.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Bioprojet
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Shionogi & Co., Ltd.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 Product Pipeline
11.9.6 SWOT Analysis
11.9.7 Key Developments
11.10 Ligand Pharmaceuticals, Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 Product Pipeline
11.10.6 SWOT Analysis
11.10.7 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. Europe Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. Europe Narcolepsy Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 3. Europe Narcolepsy Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 4. Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 5. Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 6. Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 7. Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 9. Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 10. UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 12. UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 13. France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 15. France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 16. Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 17. Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 18. Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 19. Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 20. Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
Table 21. Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
Table 22. Organic Developments Done By Companies
Table 23. Inorganic Developments Done By Companies
Table 24. Glossary of Terms, Narcolepsy Market
LIST OF FIGURES
Figure 1. US Narcolepsy Market, Revenue (US$ Mn), 2018 & 2027
Figure 2. Europe Narcolepsy Market By Type, Market Share (%), 2018
Figure 3. Europe Narcolepsy Market By Product, Market Share (%), 2018
Figure 4. Europe Narcolepsy Market By Distribution Channel, Market Share (%), 2018
Figure 5. Narcolepsy Market Segmentation
Figure 6. Europe PEST Analysis
Figure 7. Narcolepsy Market Impact Analysis Of Drivers and Restraint
Figure 8. Europe Narcolepsy Market – Revenue Forecasts and Analysis – 2018- 2027
Figure 9. Type Market Analysis and Forecasts 2018 and 2027 (%)
Figure 10. Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 11. Narcolepsy Without Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 12. Secondary Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 13. Product Market Analysis and Forecasts 2018 and 2027 (%)
Figure 14. Central Nervous System Stimulants Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 15. Sodium Oxybate Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 16. Antidepressants Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 17. Distribution Channel Market Analysis and Forecasts 2018 and 2027 (%)
Figure 18. Hospital Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 19. Retail Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)
Figure 20. Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Narcolepsy Market Revenue And Forecasts to 2027, By Country (%)
Figure 22. Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Comparative Company Analysis
Figure 28. Growth Strategies Done By The Companies In The Market, (%)
The List of Companies - Europe Narcolepsy Market
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals plc
- Arena Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- BIOPROJET
- Shionogi & Co., Ltd.
- Ligand Pharmaceuticals, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Narcolepsy Market
Jan 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jan 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jan 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jan 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jan 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)